Aspirin and P2Y12 inhibitors in treating COVID-19

被引：2
|
作者：
Khalaji, Amirmohammad [1 ]
Behnoush, Amir Hossein [1 ]
Peiman, Soheil [2 ,3 ]
机构：
[1] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[2] AdventHlth Orlando Hosp, Dept Internal Med, Orlando, FL USA
[3] AdventHlth Orlando Hosp, Dept Internal Med, 601 E Rollins St Suite 400, Orlando, FL 32803 USA
来源：
EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2023年 / 110卷
关键词：
COVID-19; Aspirin; P2Y12; inhibitors; Platelet aggregation inhibitors; Meta-analysis;
D O I：
10.1016/j.ejim.2022.11.027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / 103
页数：3
相关论文
共 50 条
  • [41] Effect of P2Y12 inhibitors on thrombus stability and endogenous fibrinolysis
    Spinthakis, Nikolaos
    Farag, Mohamed
    Gue, Ying X.
    Srinivasan, Manivannan
    Wellsted, David M.
    Gorog, Diana A.
    THROMBOSIS RESEARCH, 2019, 173 : 102 - 108
  • [42] P2Y12 receptor inhibitors for secondary prevention of ischemic stroke
    Liu, Fang
    Tantry, Udaya S.
    Gurbel, Paul A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (08) : 1149 - 1165
  • [43] Comparison of Oral P2Y12 Inhibitors in Acute Coronary Syndrome
    Ferracane, Elisa
    Bartoli, Laura
    Trippoli, Sabrina
    Messori, Andrea
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 135 : 183 - 184
  • [44] New P2Y12 inhibitors for the treatment of coronary artery disease
    Gurbel, P. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 4 - 5
  • [45] Clinical effects and outcomes with new P2Y12 inhibitors in ACS
    Collet, Jean-Philippe
    O'Connor, Stephen
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 (01) : 16 - 18
  • [46] Loading with Oral P2Y12 Receptor Inhibitors: To Crush or Not to Crush?
    Alexopoulos, Dimitrios
    Dragasis, Stylianos
    Kafkas, Nikolaos
    THROMBOSIS AND HAEMOSTASIS, 2019, 119 (07) : 1037 - 1047
  • [47] Overview of pleiotropic effects of platelet P2Y12 receptor inhibitors
    Adamski, Piotr
    Kozinski, Marek
    Ostrowska, Malgorzata
    Fabiszak, Tomasz
    Navarese, Eliano Pio
    Paciorek, Przemyslaw
    Grzesk, Grzegorz
    Kubica, Jacek
    THROMBOSIS AND HAEMOSTASIS, 2014, 112 (02) : 224 - 242
  • [48] Aspirin vs. P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation: insights from the AFIRE trial
    Fukaya, H.
    Ako, J.
    Yasuda, S.
    Kaikita, K.
    Akao, M.
    Matoba, T.
    Nakamura, M.
    Miyauchi, K.
    Hagiwara, N.
    Kimura, K.
    Hirayama, A.
    Matsui, K.
    Ogawa, H.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2997 - 2997
  • [49] Mode of action of P2Y12 antagonists as inhibitors of platelet function
    Glenn, J.
    Iyu, D. E.
    White, A. E.
    Fox, S. C.
    van Giezen, H.
    Nylander, S.
    Heptinstall, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 319 - 320
  • [50] Drug Interaction: Opioids and Oral P2Y12 Platelet Inhibitors
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1566): : 31 - 32
12345